BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16434312)

  • 1. Cytogenetic anomalies in hyaline vascular Castleman disease: report of two cases with reappraisal of histogenesis.
    Chen WC; Jones D; Ho CL; Cheng CN; Tseng JY; Tsai HP; Chang KC
    Cancer Genet Cytogenet; 2006 Jan; 164(2):110-7. PubMed ID: 16434312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty.
    Medina EA; Fuehrer NE; Miller FR; Kinney MC; Higgins RA
    Pathol Int; 2016 Sep; 66(9):535-9. PubMed ID: 27593552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stroma-rich variant of hyaline-vascular Castleman's disease: a clinicopathologic and histogenetic study].
    Xiong Y; Zhang Y; Wang Y; Na J; Li T
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan; 39(1):14-8. PubMed ID: 20388393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular dendritic cell tumor of the gastrointestinal tract: Report of a rare neoplasm and literature review.
    Agaimy A; Wünsch PH
    Pathol Res Pract; 2006; 202(7):541-8. PubMed ID: 16564140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiomyoid proliferative lesion: an unusual stroma-rich variant of Castleman's disease of hyaline-vascular type.
    Izumi M; Mochizuki M; Kuroda M; Iwaya K; Mukai K
    Virchows Arch; 2002 Oct; 441(4):400-5. PubMed ID: 12404066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
    Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
    Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal Castleman's disease complicated by follicular dendritic cell tumour.
    Desai SB; Pradhan SA; Chinoy RF
    Indian J Cancer; 2000 Dec; 37(4):129-32. PubMed ID: 12018563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of follicular and interdigitating dendritic cells in HIV-related lymphoid hyperplasia: localization of fascin.
    Said JW; Pinkus JL; Yamashita J; Mishalani S; Matsumura F; Yamashiro S; Pinkus GS
    Mod Pathol; 1997 May; 10(5):421-7. PubMed ID: 9160305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare stroma-rich variant of hyaline-vascular Castleman's disease associated with calcifying fibrous pseudotumor.
    Ma H; Jiang M; Xiao W
    Int J Clin Exp Pathol; 2015; 8(3):3362-4. PubMed ID: 26045869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal cytogenetic abnormalities in the plasma cell variant of Castleman disease.
    Reichard KK; Robinett S; Foucar MK
    Cancer Genet; 2011 Jun; 204(6):323-7. PubMed ID: 21763629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
    Vasudev Rao T; Alkindi S; Pathare AV
    Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases.
    Lin O; Frizzera G
    Am J Surg Pathol; 1997 Nov; 21(11):1295-306. PubMed ID: 9351567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular dendritic cells confirm lymphoid organization in the minor salivary glands of primary Sjögren's syndrome.
    Jonsson MV; Skarstein K
    J Oral Pathol Med; 2008 Oct; 37(9):515-21. PubMed ID: 18662248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chromosomal abnormality in hyaline vascular Castleman's disease: evidence for clonal proliferation of dysplastic stromal cells.
    Pauwels P; Dal Cin P; Vlasveld LT; Aleva RM; van Erp WF; Jones D
    Am J Surg Pathol; 2000 Jun; 24(6):882-8. PubMed ID: 10843293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of immunophenotypic features in hyaline vascular type Castleman disease.
    Chang Y; Ma Y; Chang C; Li W
    Diagn Pathol; 2023 Dec; 18(1):132. PubMed ID: 38062501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease.
    Chang KC; Wang YC; Hung LY; Huang WT; Tsou JH; M Jones D; Song HL; Yeh YM; Kao LY; Medeiros LJ
    Mod Pathol; 2014 Jun; 27(6):823-31. PubMed ID: 24201121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman disease: an update on classification and the spectrum of associated lesions.
    Cronin DM; Warnke RA
    Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary follicular dendritic cell sarcoma of the lung.
    Kovács RB; Sattar HA; Krausz T; Kas J; Berta M; Sápi Z
    Histopathology; 2006 Oct; 49(4):431-3. PubMed ID: 16978210
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive transformation of germinal center presenting with histological features of hyaline-vascular type of Castleman's disease.
    Kojima M; Nakamura S; Miyawaki S; Ohno Y; Sakata N; Masawa N
    APMIS; 2005 Apr; 113(4):288-95. PubMed ID: 15865611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.